WHO WON THE DAY? Bernard Keane, Crikey politics editor: Economic growth numbers handed the government an easy win — although the ghost of superannuation continues to extend its icy hand at the Liberals. When will they exorcise this unholy spectre from beyond the tax-effective estate planning-friendly ostentatious family vault at Waverley cemetery? But given NSW and Queensland were […]

The recommendation to list "abortion pill" mifepristone on the PBS is a victory for women's rights, but obstacles remain, including the time period it can be used and who can prescribe it. Gynaecological experts Caroline de Costa and Michael Carrette explain.

The fanfare around Health Minister Nicola Roxon’s announcement that 13 new medicines would go on the PBS is a reminder of the power and influence involved in the selection and reimbursement of prescribed medicines, writes Glenn Salkeld.

Shakira Hussein was relieved to see her MS drug make the PBS approved list, but she's not going to break open the metaphorical non-alcoholic champagne until the government reverses its decision to subject drugs recommended for subsidy to cabinet decision-making.

The cost of the PBS must be sustainable but there is a difference between saving money and ensuring cost-effectiveness. The treatment of macular degeneration provides a compelling example, writes Ken Harvey, Richard Day, Willie Campbell, and Wendy Lipworth.